Interest of vitamin D in COVID-19
© 2021 Elsevier Masson SAS. All rights reserved..
Vitamin D, which is increasingly in demand in pharmacies and increasingly prescribed, could be an asset in the treatment of Covid-19 by reducing mortality or the severity of the condition. Its potential immunomodulatory effect is currently being studied by numerous international teams of researchers.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:60 |
|---|---|
| Enthalten in: |
Actualites pharmaceutiques - 60(2021), 605 vom: 23. Apr., Seite 52-55 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Vitamine D et Covid-19 |
|---|
| Beteiligte Personen: |
Piraux, Arthur [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 21.12.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.actpha.2021.02.012 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM321715454 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM321715454 | ||
| 003 | DE-627 | ||
| 005 | 20231225180456.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.actpha.2021.02.012 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1072.xml |
| 035 | |a (DE-627)NLM321715454 | ||
| 035 | |a (NLM)33612960 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Piraux, Arthur |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Interest of vitamin D in COVID-19 |
| 246 | 3 | 3 | |a Vitamine D et Covid-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2021 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a Vitamin D, which is increasingly in demand in pharmacies and increasingly prescribed, could be an asset in the treatment of Covid-19 by reducing mortality or the severity of the condition. Its potential immunomodulatory effect is currently being studied by numerous international teams of researchers | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a immunity | |
| 650 | 4 | |a vitamin D | |
| 773 | 0 | 8 | |i Enthalten in |t Actualites pharmaceutiques |d 1961 |g 60(2021), 605 vom: 23. Apr., Seite 52-55 |w (DE-627)NLM136159966 |x 0515-3700 |7 nnns |
| 773 | 1 | 8 | |g volume:60 |g year:2021 |g number:605 |g day:23 |g month:04 |g pages:52-55 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.actpha.2021.02.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 60 |j 2021 |e 605 |b 23 |c 04 |h 52-55 | ||